Dietary Acrylamide and Cancer Risk
Author Information
Author(s): L Hagmar, M Törnqvist
Primary Institution: Lund University Hospital, Stockholm University
Hypothesis
Is there an association between dietary acrylamide intake and the risk of cancer in the large bowel, kidney, and bladder?
Conclusion
The study found no associations between dietary acrylamide and cancer risk.
Supporting Evidence
- The study included 987 cancer cases and 538 controls.
- No associations were observed between dietary acrylamide and cancer risk.
- Less than 2% of the population had a high daily intake of acrylamide.
- Statistical calculations suggest a much larger sample size is needed to detect a significant risk.
Takeaway
Eating foods with acrylamide doesn't seem to increase the chances of getting certain types of cancer.
Methodology
The study used a case-control design with dietary intake estimates from food frequency questionnaires.
Potential Biases
Possible nondifferential misclassification of exposure due to imprecise dietary data.
Limitations
Limited information on acrylamide intake and potential misclassification of exposure.
Participant Demographics
Swedish population with 987 cancer cases and 538 healthy controls.
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website